These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3155500)
1. Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement. Shah PK; Amin DK; Hulse S; Shellock F; Swan HJ Circulation; 1985 Feb; 71(2):326-31. PubMed ID: 3155500 [TBL] [Abstract][Full Text] [Related]
2. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043. Uretsky BF; Valdes AM; Reddy PS Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328 [TBL] [Abstract][Full Text] [Related]
3. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure. Petein M; Levine TB; Cohn JN Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778 [TBL] [Abstract][Full Text] [Related]
4. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients. Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076 [TBL] [Abstract][Full Text] [Related]
5. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response. Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS J Am Coll Cardiol; 1985 Jun; 5(6):1414-21. PubMed ID: 3158689 [TBL] [Abstract][Full Text] [Related]
6. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation. Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874 [TBL] [Abstract][Full Text] [Related]
16. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure. Amin DK; Shah PK; Hulse S; Shellock F Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182 [TBL] [Abstract][Full Text] [Related]
17. Results of long-term vasodilator therapy in patients with refractory congestive heart failure. Walsh WF; Greenberg BH Circulation; 1981 Sep; 64(3):499-505. PubMed ID: 7261282 [TBL] [Abstract][Full Text] [Related]
18. Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance. Crawford MH; Richards KL; Sodums MT; Kennedy GT Am J Cardiol; 1984 Apr; 53(8):1051-3. PubMed ID: 6230926 [TBL] [Abstract][Full Text] [Related]
19. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. Simonton CA; Chatterjee K; Cody RJ; Kubo SH; Leonard D; Daly P; Rutman H J Am Coll Cardiol; 1985 Aug; 6(2):453-9. PubMed ID: 4019930 [TBL] [Abstract][Full Text] [Related]
20. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile. Galie N; Branzi A; Magnani G; Melandri G; Caldarera I; Rapezzi C; Grattoni C; Magnani B Cardiovasc Drugs Ther; 1993 Jun; 7(3):337-47. PubMed ID: 8364004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]